Annual EBIT
-$72.39 M
-$9.10 M-14.39%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual earnings before interest & taxes is -$72.39 million, with the most recent change of -$9.10 million (-14.39%) on December 31, 2023.
- During the last 3 years, ABUS annual EBIT has fallen by -$12.66 million (-21.19%).
- ABUS annual EBIT is now -317.28% below its all-time high of $33.32 million, reached on December 31, 2012.
Performance
ABUS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$19.69 M
+$74.00 K+0.37%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly earnings before interest & taxes is -$19.69 million, with the most recent change of +$74.00 thousand (+0.37%) on September 30, 2024.
- Over the past year, ABUS quarterly EBIT has dropped by -$1.86 million (-10.41%).
- ABUS quarterly EBIT is now -148.71% below its all-time high of $40.42 million, reached on December 31, 2012.
Performance
ABUS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$76.55 M
+$370.00 K+0.48%
September 30, 2024
Summary
- As of February 7, 2025, ABUS TTM earnings before interest & taxes is -$76.55 million, with the most recent change of +$370.00 thousand (+0.48%) on September 30, 2024.
- Over the past year, ABUS TTM EBIT has dropped by -$2.47 million (-3.33%).
- ABUS TTM EBIT is now -328.93% below its all-time high of $33.44 million, reached on December 31, 2012.
Performance
ABUS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ABUS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.4% | -10.4% | -3.3% |
| 3 y3 years | -21.2% | +8.9% | -21.0% |
| 5 y5 years | -18.4% | +8.9% | -21.0% |
ABUS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.4% | +1.4% | -82.0% | +8.9% | -22.6% | +0.5% |
| 5 y | 5-year | -21.2% | +55.9% | -82.0% | +16.8% | -28.1% | +53.4% |
| alltime | all time | -317.3% | +85.2% | -148.7% | +92.4% | -328.9% | +84.4% |
Arbutus Biopharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$19.69 M(-0.4%) | -$76.55 M(-0.5%) |
| Jun 2024 | - | -$19.76 M(+10.8%) | -$76.92 M(+3.8%) |
| Mar 2024 | - | -$17.83 M(-7.5%) | -$74.08 M(+2.3%) |
| Dec 2023 | -$72.39 M(+14.4%) | -$19.27 M(-3.9%) | -$72.39 M(-3.2%) |
| Sep 2023 | - | -$20.06 M(+18.5%) | -$74.75 M(+4.1%) |
| Jun 2023 | - | -$16.92 M(+4.8%) | -$71.83 M(+4.7%) |
| Mar 2023 | - | -$16.14 M(-25.4%) | -$68.61 M(+8.4%) |
| Dec 2022 | -$63.29 M(-13.8%) | -$21.62 M(+26.2%) | -$63.29 M(+1.4%) |
| Sep 2022 | - | -$17.14 M(+25.0%) | -$62.42 M(-2.0%) |
| Jun 2022 | - | -$13.71 M(+26.8%) | -$63.68 M(-7.2%) |
| Mar 2022 | - | -$10.81 M(-47.9%) | -$68.60 M(-6.5%) |
| Dec 2021 | -$73.39 M(+22.9%) | -$20.76 M(+12.9%) | -$73.39 M(+6.6%) |
| Sep 2021 | - | -$18.40 M(-1.2%) | -$68.87 M(+1.0%) |
| Jun 2021 | - | -$18.62 M(+19.3%) | -$68.16 M(+9.0%) |
| Mar 2021 | - | -$15.61 M(-3.9%) | -$62.52 M(+4.7%) |
| Dec 2020 | -$59.73 M(-63.6%) | -$16.25 M(-8.1%) | -$59.73 M(-11.0%) |
| Sep 2020 | - | -$17.68 M(+36.1%) | -$67.15 M(-53.2%) |
| Jun 2020 | - | -$12.99 M(+1.3%) | -$143.53 M(-6.7%) |
| Mar 2020 | - | -$12.82 M(-45.8%) | -$153.85 M(-6.3%) |
| Dec 2019 | -$164.27 M(+168.8%) | -$23.66 M(-74.8%) | -$164.27 M(+3.5%) |
| Sep 2019 | - | -$94.06 M(+303.5%) | -$158.74 M(+69.9%) |
| Jun 2019 | - | -$23.31 M(+0.3%) | -$93.43 M(+39.4%) |
| Mar 2019 | - | -$23.24 M(+28.2%) | -$67.03 M(+9.7%) |
| Dec 2018 | -$61.12 M(-43.7%) | -$18.13 M(-37.0%) | -$61.12 M(-40.8%) |
| Sep 2018 | - | -$28.75 M(-1030.3%) | -$103.17 M(+20.1%) |
| Jun 2018 | - | $3.09 M(-117.8%) | -$85.93 M(-19.8%) |
| Mar 2018 | - | -$17.32 M(-71.2%) | -$107.21 M(-1.2%) |
| Dec 2017 | -$108.47 M(-77.8%) | -$60.18 M(+422.2%) | -$108.47 M(-64.7%) |
| Sep 2017 | - | -$11.52 M(-36.6%) | -$307.13 M(-2.6%) |
| Jun 2017 | - | -$18.19 M(-2.1%) | -$315.20 M(-35.9%) |
| Mar 2017 | - | -$18.59 M(-92.8%) | -$491.88 M(+0.6%) |
| Dec 2016 | -$489.17 M(+520.0%) | -$258.83 M(+1220.9%) | -$489.17 M(+83.7%) |
| Sep 2016 | - | -$19.59 M(-89.9%) | -$266.32 M(-0.2%) |
| Jun 2016 | - | -$194.86 M(+1127.6%) | -$266.87 M(+210.1%) |
| Mar 2016 | - | -$15.87 M(-55.9%) | -$86.07 M(+9.1%) |
| Dec 2015 | -$78.90 M(+139.3%) | -$35.98 M(+78.6%) | -$78.90 M(+47.0%) |
| Sep 2015 | - | -$20.15 M(+43.3%) | -$53.66 M(+33.0%) |
| Jun 2015 | - | -$14.06 M(+61.4%) | -$40.36 M(+13.0%) |
| Mar 2015 | - | -$8.71 M(-18.9%) | -$35.73 M(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$32.97 M(+171.3%) | -$10.75 M(+57.0%) | -$32.97 M(+33.7%) |
| Sep 2014 | - | -$6.84 M(-27.4%) | -$24.66 M(+14.9%) |
| Jun 2014 | - | -$9.42 M(+58.2%) | -$21.47 M(+42.0%) |
| Mar 2014 | - | -$5.96 M(+144.6%) | -$15.12 M(+24.4%) |
| Dec 2013 | -$12.15 M(-136.5%) | -$2.44 M(-33.3%) | -$12.15 M(-139.6%) |
| Sep 2013 | - | -$3.65 M(+18.9%) | $30.70 M(-5.7%) |
| Jun 2013 | - | -$3.07 M(+2.6%) | $32.55 M(-1.6%) |
| Mar 2013 | - | -$2.99 M(-107.4%) | $33.08 M(-1.1%) |
| Dec 2012 | $33.32 M(-411.6%) | $40.42 M(-2343.5%) | $33.44 M(-448.4%) |
| Sep 2012 | - | -$1.80 M(-29.0%) | -$9.60 M(+1.9%) |
| Jun 2012 | - | -$2.54 M(-3.9%) | -$9.42 M(-11.3%) |
| Mar 2012 | - | -$2.64 M(+0.9%) | -$10.62 M(-4.7%) |
| Dec 2011 | -$10.69 M(+62.1%) | -$2.62 M(+61.4%) | -$11.14 M(+130.8%) |
| Sep 2011 | - | -$1.62 M(-56.7%) | -$4.83 M(-14.0%) |
| Jun 2011 | - | -$3.74 M(+18.2%) | -$5.62 M(+0.5%) |
| Mar 2011 | - | -$3.17 M(-185.6%) | -$5.59 M(-14.9%) |
| Dec 2010 | -$6.60 M(-18.5%) | $3.70 M(-253.4%) | -$6.57 M(-44.3%) |
| Sep 2010 | - | -$2.41 M(-35.1%) | -$11.79 M(-0.1%) |
| Jun 2010 | - | -$3.71 M(-10.4%) | -$11.80 M(+17.9%) |
| Mar 2010 | - | -$4.14 M(+171.8%) | -$10.01 M(+31.5%) |
| Dec 2009 | -$8.10 M(-3.0%) | -$1.52 M(-37.0%) | -$7.61 M(+26.1%) |
| Sep 2009 | - | -$2.42 M(+26.1%) | -$6.04 M(-3.7%) |
| Jun 2009 | - | -$1.92 M(+10.0%) | -$6.27 M(-33.8%) |
| Mar 2009 | - | -$1.75 M(-3389.6%) | -$9.47 M(+10.6%) |
| Dec 2008 | -$8.34 M(-416.1%) | $53.10 K(-102.0%) | -$8.56 M(+0.4%) |
| Sep 2008 | - | -$2.65 M(-48.3%) | -$8.53 M(+101.7%) |
| Jun 2008 | - | -$5.12 M(+508.8%) | -$4.23 M(-493.1%) |
| Mar 2008 | - | -$841.60 K(-1082.0%) | $1.08 M(-43.9%) |
| Dec 2007 | $2.64 M(-86.6%) | $85.70 K(-94.8%) | $1.92 M(+4.7%) |
| Sep 2007 | - | $1.65 M(+809.3%) | $1.83 M(+909.3%) |
| Jun 2007 | - | $181.50 K | $181.50 K |
| Dec 2006 | $19.68 M(-1909.8%) | - | - |
| Dec 2005 | -$1.09 M(-95.3%) | - | - |
| Dec 2004 | -$23.38 M(-32.5%) | - | - |
| Dec 2003 | -$34.65 M(+44.7%) | - | - |
| Dec 2002 | -$23.95 M(+45.2%) | - | - |
| Dec 2001 | -$16.49 M(+53.5%) | - | - |
| Dec 2000 | -$10.74 M(+31.5%) | - | - |
| Dec 1999 | -$8.17 M(-6.6%) | - | - |
| Dec 1998 | -$8.75 M | - | - |
FAQ
- What is Arbutus Biopharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Arbutus Biopharma?
- What is Arbutus Biopharma annual EBIT year-on-year change?
- What is Arbutus Biopharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly EBIT year-on-year change?
- What is Arbutus Biopharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Arbutus Biopharma?
- What is Arbutus Biopharma TTM EBIT year-on-year change?
What is Arbutus Biopharma annual earnings before interest & taxes?
The current annual EBIT of ABUS is -$72.39 M
What is the all time high annual EBIT for Arbutus Biopharma?
Arbutus Biopharma all-time high annual earnings before interest & taxes is $33.32 M
What is Arbutus Biopharma annual EBIT year-on-year change?
Over the past year, ABUS annual earnings before interest & taxes has changed by -$9.10 M (-14.39%)
What is Arbutus Biopharma quarterly earnings before interest & taxes?
The current quarterly EBIT of ABUS is -$19.69 M
What is the all time high quarterly EBIT for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly earnings before interest & taxes is $40.42 M
What is Arbutus Biopharma quarterly EBIT year-on-year change?
Over the past year, ABUS quarterly earnings before interest & taxes has changed by -$1.86 M (-10.41%)
What is Arbutus Biopharma TTM earnings before interest & taxes?
The current TTM EBIT of ABUS is -$76.55 M
What is the all time high TTM EBIT for Arbutus Biopharma?
Arbutus Biopharma all-time high TTM earnings before interest & taxes is $33.44 M
What is Arbutus Biopharma TTM EBIT year-on-year change?
Over the past year, ABUS TTM earnings before interest & taxes has changed by -$2.47 M (-3.33%)